Row
T
TAKAI Stock Diagnostic Report
Form 144 Takeda Pharmaceutical Company Limited For: 13 July
The submission of Form 144 by Takeda Pharmaceutical indicates the intention of insiders to sell shares, reflecting a general change in equity rather than a fundamental business shift for the company.
View Source Article ↗AI CATALYST SCORE20 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time